Terms: = Head and neck cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
65 results:
1. Relationship between ERCC1 and xpc polymorphisms and the susceptibility to head and neck carcinoma: A systematic review, meta-analysis, and trial sequential analysis.
Imani MM; Akbari S; Shalchi M; Sadeghi E; Sadeghi M
Arch Oral Biol; 2024 Jun; 162():105955. PubMed ID: 38479279
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Polymorphisms of xpc, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among head and neck cancer Patients: A Hospital Based Study from Maharashtra.
Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
[TBL] [Abstract] [Full Text] [Related]
4. The value of deep neural networks in the pathological classification of thyroid tumors.
Deng C; Li D; Feng M; Han D; Huang Q
Diagn Pathol; 2023 Aug; 18(1):95. PubMed ID: 37598149
[TBL] [Abstract] [Full Text] [Related]
5. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Panje C; Hayoz S; Eisterer W; Hess V; Thuss-Patience P; Schacher S; Dürr D; Wagner AD; Girschikofsky M; Eboulet E; Stahl M; Ruhstaller T
Eur J Cancer; 2022 Dec; 177():186-193. PubMed ID: 36368252
[TBL] [Abstract] [Full Text] [Related]
6. Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of head and neck Squamous Cell Carcinomas in a Chinese Population.
Liang Y; Zhang L; Chen Z; Chen J; Fang S; Zhang T; Zhu Y; Liu J; Li B; Shao Y; Xing J; Zhang S; Han P
Dis Markers; 2022; 2022():4959737. PubMed ID: 36118674
[TBL] [Abstract] [Full Text] [Related]
7. Interaction of DNA Repair Gene xpc With Smoking and Betel Quid Chewing Behaviors of Oral cancer.
Wu CN; Chang WS; Shih LC; Wang YC; Lee HT; Yu CC; Wang ZH; Mong MC; Hsia TC; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2021; 18(3 Suppl):441-449. PubMed ID: 33994366
[TBL] [Abstract] [Full Text] [Related]
8. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract] [Full Text] [Related]
9. Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal cancer: An Intergroup Phase III Trial of the Swiss Group for Clinical cancer Research (SAKK 75/08).
von Holzen U; Schmidt S; Hayoz S; Steffen T; Grieder F; Bartsch D; Schnider A; Knoefel WT; Piessen G; Kettelhack C; Marti WR; Schäfer M; Függer R; Köigsrainer A; Gloor B; Furrer M; Gérard MA; Hawle H; Walz MK; Alesina P; Ruhstaller T;
Ann Surg; 2022 Jun; 275(6):1130-1136. PubMed ID: 33055589
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Polymorphisms Along with Dietary and Environmental Factors Enhance the Susceptibility to Nasopharyngeal Carcinoma in Nagaland of Northeast India.
Keppen C; Barooah P; Borthakur P; Saikia S; Deka M; Bhattacharjee S; Keppen J; Khamo V; Medhi S
Biochem Genet; 2020 Aug; 58(4):533-550. PubMed ID: 32557268
[TBL] [Abstract] [Full Text] [Related]
11. High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
Fehr M; Hawle H; Hayoz S; Thuss-Patience P; Schacher S; Riera Knorrenschild J; Dürr D; Knoefel WT; Rumpold H; Bitzer M; Zweifel M; Samaras P; Mey U; Küng M; Winterhalder R; Eisterer W; Hess V; Gérard MA; Templeton A; Stahl M; Ruhstaller T; ; ; ;
BMC Cancer; 2020 Feb; 20(1):166. PubMed ID: 32111181
[TBL] [Abstract] [Full Text] [Related]
12. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes.
Santos LS; Gomes BC; Bastos HN; Gil OM; Azevedo AP; Ferreira TC; Limbert E; Silva SN; Rueff J
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31374908
[TBL] [Abstract] [Full Text] [Related]
14. Genetic variants in nucleotide excision repair pathway predict survival of esophageal squamous cell cancer patients receiving platinum-based chemotherapy.
Zhang R; Zhou F; Cheng L; Yu A; Zhu M; Wang M; Zhang Z; Xiang J; Wei Q
Mol Carcinog; 2018 Nov; 57(11):1553-1565. PubMed ID: 30035334
[TBL] [Abstract] [Full Text] [Related]
15. Modulation of risk of squamous cell carcinoma head and neck in North Indian population with polymorphisms in xeroderma pigmentosum complementation Group C gene.
Yadav SK; Singh S; Gupta S; Brahma Bhatt ML; Mishra DP; Roy D; Sanyal S
J Cancer Res Ther; 2018; 14(3):651-657. PubMed ID: 29893334
[TBL] [Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).
Ruhstaller T; Thuss-Patience P; Hayoz S; Schacher S; Knorrenschild JR; Schnider A; Plasswilm L; Budach W; Eisterer W; Hawle H; Mariette C; Hess V; Mingrone W; Montemurro M; Girschikofsky M; Schmidt SC; Bitzer M; Bedenne L; Brauchli P; Stahl M; ; ; ;
Ann Oncol; 2018 Jun; 29(6):1386-1393. PubMed ID: 29635438
[TBL] [Abstract] [Full Text] [Related]
17. GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in head and neck cancer Patients treated with Cisplatin Chemoradiation.
Carron J; Lopes-Aguiar L; Costa EFD; Nogueira GAS; Lima TRP; Pincinato EC; Visacri MB; Quintanilha JCF; Moriel P; Lourenço GJ; Lima CSP
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):520-525. PubMed ID: 28686330
[TBL] [Abstract] [Full Text] [Related]
18. Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Zhou F; Zhu M; Wang M; Qiu L; Cheng L; Jia M; Xiang J; Wei Q
J Transl Med; 2016 May; 14(1):154. PubMed ID: 27246611
[TBL] [Abstract] [Full Text] [Related]
19. Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer.
Gusella M; Giacopuzzi S; Bertolaso L; Zanoni A; Pezzolo E; Modena Y; Menon D; Paganin P; Weindelmayer J; Crepaldi G; De Manzoni G; Pasini F
Pharmacogenomics J; 2017 Jun; 17(3):252-257. PubMed ID: 26927287
[TBL] [Abstract] [Full Text] [Related]
20. XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Lopes-Aguiar L; Costa EF; Nogueira GA; Lima TR; Visacri MB; Pincinato EC; Calonga L; Mariano FV; de Almeida Milani Altemani AM; Altemani JM; Coutinho-Camillo CM; Ribeiro Alves MA; Moriel P; Ramos CD; Chone CT; Lima CS
Oncotarget; 2017 Mar; 8(10):16190-16201. PubMed ID: 26918827
[TBL] [Abstract] [Full Text] [Related]
[Next]
